Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

8:47 AM ET 8-K
Capital Raise WhiteHawk Minerals Corp. WHK

WhiteHawk Minerals Capital Raise of $75M

WhiteHawk Minerals Corp. entered into a securities purchase agreement for a private placement of 2,873,563 shares of Class A common stock at $26.10 per share. The company expects to raise approximately $75.0 million in gross proceeds to fund recently announced acquisitions and for general corporate purposes. The transaction is expected to close on September 21, 2026, and includes a registration rights agreement for the resale of the shares.

Value
$75M
5:12 PM ET 8-K
Capital Raise Capital One Prime Auto Receivables Trust 2026-1

Capital One Prime Auto Receivables Trust 2026-1 Capital Raise of $1.5B

Capital One Prime Auto Receivables Trust 2026-1 completed the issuance and sale of $1.5 billion in asset-backed notes secured by a pool of motor vehicle retail installment sales contracts. The offering included several classes of Class A notes sold to a syndicate of underwriters led by J.P. Morgan Securities and BofA Securities.

Value
$1.5B
Counterparty
J.P. Morgan Securities LLC
7:13 AM ET 8-K
Capital Raise CXJ Group CO., Ltd ECXJ

CXJ Group CO Capital Raise

CXJ Group Co., Limited entered into a subscription agreement with Suwen Wang for the private placement of 124,000 shares of common stock. The transaction raised approximately $72,912 in net proceeds, which the company intends to use for general working capital.

Counterparty
Suwen Wang
6:03 AM ET 8-K
Capital Raise Cenntro Inc. CENN

Cenntro Capital Raise of $57M

Cenntro Inc. closed a private placement of 15,120,000 shares of common stock at a price of $3.773 per share, raising approximately $57.05 million in gross proceeds. The company amended an earlier agreement to increase the offering size and intends to use the funds for working capital and general corporate purposes.

Value
$57M
Counterparty
Accredited Investors
6:02 AM ET 8-K
Capital Raise Bcb Bancorp Inc BCBP

Bcb Bancorp Capital Raise of $85.2M

BCB Bancorp, Inc. priced an underwritten public offering of 11,000,000 shares of common stock at $7.75 per share, generating gross proceeds of $85.25 million. The company intends to use the net proceeds for general corporate purposes, including maintaining liquidity, supporting bank capital, and reducing debt. Piper Sandler & Co. is acting as the sole book-running manager for the offering.

Value
$85.2M
Counterparty
Piper Sandler & Co.
6:01 AM ET 8-K
Capital Raise Beta Bionics, Inc. BBNX

Beta Bionics Capital Raise of $150M

Beta Bionics, Inc. priced a public offering of 7,652,175 shares of common stock and pre-funded warrants for gross proceeds of approximately $150.0 million. The offering was priced at $17.25 per share, and the company granted underwriters a 30-day option to purchase up to an additional 1,304,348 shares. Proceeds are intended for general corporate purposes, including the commercialization of its Mint product and manufacturing facility expansion.

Value
$150M
Counterparty
J.P. Morgan Securities LLC, Piper Sandler & Co., Wells Fargo Securities, LLC and Leerink Partners LLC
5:25 PM ET 8-K
Capital Raise Tenon Medical, Inc. TNON

Tenon Medical Capital Raise of $2.87M

Tenon Medical entered into an inducement agreement with an institutional investor to exercise existing warrants for 572,179 shares of common stock at $5.02 per share. In exchange for the cash exercise, the company issued new unregistered five-year warrants to purchase up to 858,269 shares at the same exercise price. The transaction generated approximately $2.87 million in gross proceeds for working capital and general corporate purposes.

Value
$2.87M
Counterparty
WallachBeth Capital LLC
5:13 PM ET 8-K
Capital Raise Clene Inc. CLNN

Clene Capital Raise of $4M

Clene Inc. entered into a securities purchase agreement for a $4.0 million registered direct offering of 1,219,513 shares of common stock at $3.28 per share. The offering was led by the company's Chairman and CEO alongside existing investors to fund regulatory filings for its lead drug candidate, CNM-Au8, and general corporate purposes. The proceeds are expected to extend the company's cash runway through mid-first quarter 2027.

Value
$4M
Counterparty
David Matlin, Kensington Capital Holdings, and other existing stockholders
4:56 PM ET 8-K
Capital Raise Golub Capital BDC 4, Inc.

Golub Capital BDC 4 Capital Raise of $68.1M

Golub Capital BDC 4, Inc. issued a capital drawdown notice to its stockholders for the sale of approximately 4.54 million shares of common stock. The transaction is expected to raise $68.07 million in gross proceeds and is scheduled to close on or around September 24, 2026.

Value
$68.1M
Counterparty
Stockholders
4:53 PM ET 8-K
Capital Raise Bcb Bancorp Inc BCBP

Bcb Bancorp Capital Raise

BCB Bancorp has launched an underwritten public offering of its common stock to raise capital for general corporate purposes and to support the bank's capital ratios. Simultaneously, the company announced a major balance sheet cleanup involving the marketing for sale of approximately $210 million in problem loans and the divestiture of its cannabis-related business lines. Due to these asset sales and a $50 million tax valuation allowance, the company expects to report a significant net loss between $126.2 million and $136.1 million for the third quarter of 2026.

Counterparty
Piper Sandler & Co.
4:36 PM ET 8-K
Capital Raise Sysco Corp SYY

Sysco Capital Raise of $1000M

Sysco Corporation closed a public offering of 12,345,679 shares of common stock at $81.00 per share, generating approximately $967.4 million in net proceeds. The company intends to use the funds to finance a portion of its pending acquisition of JRD Unico, Inc. and Warehouse Realty, LLC. The underwriters were also granted a 30-day option to purchase an additional 1,851,851 shares to cover overallotments.

Value
$1000M
Counterparty
Goldman Sachs & Co. LLC
4:31 PM ET 8-K
Capital Raise Ares Industrial Real Estate Income Trust Inc.

Ares Industrial Real Estate Income Trust Capital Raise of $5.1B

Ares Industrial Real Estate Income Trust reported its monthly Net Asset Value (NAV) as of August 31, 2026, totaling approximately $5.1 billion across its share classes. The filing provides an update on its continuous public offering and DST Program, noting that transaction prices for October 1, 2026, will be based on the August 31 NAV per share.

Value
$5.1B
4:22 PM ET 8-K
Capital Raise BuzzFeed, Inc. BZFD

BuzzFeed Capital Raise of $1.8M

BuzzFeed, Inc. entered into a share purchase agreement to issue 1,700,000 new shares of Class A common stock to Allen Family Digital, LLC, an affiliate of Chairman Byron Allen. The private placement raised approximately $1.8 million at a price of $1.06 per share, representing the closing price on the day prior to the agreement.

Value
$1.8M
Counterparty
Allen Family Digital, LLC
4:02 PM ET 8-K
Capital Raise Stellus Private Credit BDC

Stellus Private Credit BDC Capital Raise of $10M

Stellus Private Credit BDC issued a capital drawdown notice to its investors for the sale of 661,378 common shares at an aggregate price of $10 million. The transaction is conducted via subscription agreements where investors fund capital commitments on an as-needed basis, with the closing expected around September 29, 2026.

Value
$10M
9:28 AM ET 8-K
Capital Raise My Size, Inc. MYSZ

My Size Capital Raise of $2.5M

My Size, Inc. entered into a securities purchase agreement for a private placement of 1,308,901 pre-funded warrants and associated Series C and D warrants, priced at-the-market under Nasdaq rules. The offering is expected to generate approximately $2.5 million in gross proceeds to be used for general corporate purposes and working capital. The company has also agreed to file a resale registration statement for the shares underlying the warrants within 15 days of the agreement.

Value
$2.5M
Counterparty
H.C. Wainwright & Co. (Placement Agent)
8:30 AM ET 8-K
Capital Raise La Rosa Holdings Corp. SRTM

La Rosa Holdings Capital Raise

La Rosa Holdings Corp. entered into a Securities Purchase Agreement with an institutional investor for the sale of 200 shares of Series E Convertible Preferred Stock at $1,000 per share. The company received gross proceeds of $200,000 and the agreement includes an option for the investor to purchase additional shares at future closings.

Counterparty
institutional investor
6:04 AM ET 8-K
Capital Raise Beneficient BENF

Beneficient Capital Raise

Beneficient entered into subscription agreements with three of its executives and directors for the private placement of 33,019 shares of Class A common stock. The shares were sold at a price of $1.06 per share to CEO James G. Silk, Chief Fiduciary Officer Derek L. Fletcher, and Director Peter T. Cangany, Jr.

Counterparty
Peter T. Cangany, Jr., Derek L. Fletcher, and James G. Silk
6:00 AM ET 8-K
Capital Raise XCF Global, Inc. SAFX

XCF Global Capital Raise of $1M

XCF Global, Inc. entered into a warrant purchase agreement with GL PART SPV II, LLC, raising $1.0 million in a private placement. The company issued an initial warrant to purchase up to 6,891,798 shares of Class A Common Stock at an exercise price of $2.50 per share. This transaction was a condition to the effectiveness of an amendment to the company's pending business combination agreement.

Value
$1M
Counterparty
GL PART SPV II, LLC
5:05 PM ET 8-K
Capital Raise Laser Photonics Corp LASE

Laser Photonics Capital Raise of $7.9M

Laser Photonics Corp closed a public offering of 10,500,000 shares of common stock and accompanying warrants at a combined price of $0.75 per share. The transaction generated gross proceeds of approximately $7.9 million before fees and expenses. The company intends to use the proceeds for research and development, potential acquisitions, and general working capital.

Value
$7.9M
4:58 PM ET 8-K
Capital Raise Rent the Runway, Inc. RENT

Rent the Runway Capital Raise of $15M

Rent the Runway announced a record date of September 25, 2026, for its previously announced $15 million rights offering. The company intends to distribute transferable subscription rights to purchase up to 4,225,352 shares of Class A common stock at a subscription price of at least $3.55 per share.

Value
$15M
4:09 PM ET 8-K
Capital Raise Grayscale Bittensor Trust (TAO) GTAO

Grayscale Bittensor Trust Capital Raise of $651K

Grayscale Bittensor Trust (TAO) issued 148,800 shares to accredited investors in private placement transactions for an aggregate of 2,814.13415038 TAO, valued at approximately $650,589. The shares were issued at varying prices based on the Trust's NAV per share, bringing the total shares outstanding to 2,842,300 as of September 15, 2026.

Value
$651K
Counterparty
Accredited investors
4:07 PM ET 8-K
Capital Raise Tempest Therapeutics, Inc. TPST

Tempest Therapeutics Capital Raise of $2.5M

Tempest Therapeutics entered into a securities purchase agreement with an institutional investor for a private placement of pre-funded warrants and accompanying Series C and D warrants. The company raised approximately $2.5 million in gross proceeds, with the potential for an additional $5 million upon the cash exercise of the common warrants. Proceeds are intended for working capital and general corporate purposes.

Value
$2.5M
Counterparty
institutional investor
9:28 AM ET 8-K
Capital Raise Healthstream Inc HSTM

Healthstream Capital Raise of $40M

HealthStream completed a $40 million private placement of 1,355,932 newly issued shares of common stock to WJRJJ Ventures, LLC at $29.50 per share. Simultaneously, CEO Robert A. Frist, Jr. sold an additional 144,068 shares to the same investor for $4.25 million. The company intends to use the proceeds for general corporate purposes, including potential acquisitions and strategic initiatives.

Value
$40M
Counterparty
WJRJJ Ventures, LLC
9:26 AM ET 8-K
Capital Raise Dream Finders Homes, Inc. DFH

Dream Finders Homes Capital Raise of $225M

Dream Finders Homes, Inc. entered into subscription agreements with institutional investors to sell 225,000 shares of newly-created Series B Convertible Preferred Stock for $225 million. The proceeds were used to redeem existing Series A Preferred Stock, with a second closing of $450 million contingent upon the completion of the company's pending merger with Beazer Homes USA, Inc.

Value
$225M
Counterparty
institutional investors
8:58 AM ET 8-K
Capital Raise GT Biopharma, Inc. GTBP

GT Biopharma Capital Raise of $7.45M

GT Biopharma entered into a securities purchase agreement for a private placement of up to 8,277.778 shares of Series M 10% Convertible Preferred Stock and associated warrants for an initial purchase price of $7.45 million. The agreement includes 'Greenshoe Rights' allowing purchasers to acquire additional preferred stock with a stated value of up to $33.33 million for an additional $30 million. The preferred stock is convertible into common stock at an initial conversion price of $6.10 per share.

Value
$7.45M
7:15 AM ET 8-K
Capital Raise FibroBiologics, Inc. FBLG

FibroBiologics Capital Raise of $500K

FibroBiologics entered into a securities purchase agreement with its Chief Scientific Officer, Hamid Khoja, Ph.D., for a private placement of 298,508 shares and equal warrants. The offering is expected to raise approximately $0.5 million in gross proceeds for general corporate purposes and working capital. The securities were priced at $1.675 per unit, representing the previous day's closing bid price plus a warrant premium.

Value
$500K
Counterparty
Hamid Khoja, Ph.D.
6:04 AM ET 8-K
Capital Raise Tyra Biosciences, Inc. TYRA

Tyra Biosciences Capital Raise of $400M

Tyra Biosciences entered into an underwriting agreement to raise approximately $400 million through the sale of 9,079,000 shares of common stock and 9,078,529 pre-funded warrants. The offering was led by RA Capital Management and includes participation from several institutional investors to fund the development of dabogratinib and other pipeline programs. The common stock is priced at $22.03 per share, with the offering expected to close on September 15, 2026.

Value
$400M
Counterparty
Jefferies LLC
4:36 PM ET 8-K
Capital Raise Elmet Group Co. ELMT

Elmet Group Capital Raise of $450M

The Elmet Group received a $450 million committed investment from the U.S. Department of War's Economic Defense Unit to accelerate domestic tungsten manufacturing and secure critical mineral supply chains. The funding will support over $165 million in facility expansions across Maine, Michigan, and Ohio, as well as global mining operations in Australia and Spain. Additionally, the company secured a separate agreement worth up to $2 billion to support the National Defense Stockpile.

Value
$450M
Counterparty
United States Department of War
Earnings call
Aug 30, 2033, 9:00 AM ET

“This investment represents an important step toward securing a resilient supply of tungsten, a material that is critical to America’s defense, industrial, and economic future. The Elmet Group’s vertically integrated production capabilities, sourcing strategy, and commitment to expanding capacity positions our company to play a meaningful role in strengthening supply chains.”

Peter V. Anania, The Elmet Group CEO and Chairman
4:11 PM ET 8-K
Capital Raise PDS Biotechnology Corp PDSB

PDS Biotechnology Capital Raise of $11.3M

PDS Biotechnology completed the initial closing of a PIPE financing led by Nant Capital, raising $11.3 million in gross proceeds through the sale of common stock and warrants. The company also announced a contingent milestone closing for an additional $11 million and appointed Dr. Patrick Soon-Shiong and James Banaag to its Board of Directors. Proceeds will be used to repay $4.6 million in debt to Yorkville and advance the PDS0301 clinical program.

Value
$11.3M
Counterparty
Nant Capital, LLC
4:02 PM ET 8-K
Capital Raise Yarrow Bioscience, Inc. YARW

Yarrow Bioscience Capital Raise of $172M

Yarrow Bioscience entered into an underwriting agreement to sell 5,769,231 shares of common stock at $26.00 per share. The underwriters fully exercised their option to purchase an additional 865,384 shares, bringing the total expected net proceeds to approximately $161.8 million after expenses.

Value
$172M
Counterparty
Jefferies LLC, TD Securities (USA) LLC and Guggenheim Securities, LLC

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.